MPM BioImpact — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Deka Biosciencesdekabiosciences.comSeries B · Sep 2023 · $20M
BiotechGermantown, US
John Mumm(Executive Officer, Director)Vera Mumm(Executive Officer)Pavel Khrimian(Executive Officer, Director)Lucio Iannone(Director)Sally (Yuanheng) Wang(Director)
Co-investorsLumira VenturesPlains VenturesEcho Investment CapitalLeaps by Bayer
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ReNAgade Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.